Back to search

Article

Spatially informed comprehensive tumor transcriptomic profiling stratifies clinical outcomes in early triple negative breast cancer

2026-07-09

Abstract excerpt

The intensification of neoadjuvant therapy for early triple-negative breast cancer (eTNBC) – through the addition of carboplatin to standard chemotherapy and the incorporation of pembrolizumab – has markedly improved prognosis in recent years. However, this escalation carries a substantial risk of toxicity, and not all patients require the full regimen to achieve benefit. Realizing individualized treatment strateg...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fef835cc-701f-569d-af1d-56b6d970e35a
DOI
10.64898/2026.07.06.26357224
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Spatially informed comprehensive tumor transcriptomic profiling stratifies clinical outcomes in early triple negative breast cancerDOI 10.64898/2026.07.06.26357224
Select a neighboring publication to make it the new centre.